Beta Drugs Ltd. Financials

10:34 Jun 19

Beta Drugs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1787.55
+0.00 (+0.00%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Beta Drugs Ltd. Financials

Beta Drugs Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1787.55
+0.00 (+0.00%)
10:34 Jun 19
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

25/100
Expensive Valuation

Technical

45/100
Technically Neutral

Strength

5

Weakness

6

Opportunity

0

Threats

0

21.52 %

ROE %

9.72 %

ROA %

42.02

EPS

195.25

BVPS

11.70 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
116.12 183.84 227.11 295.71 362.36
Operating Expenses +
91.38 141.14 173.99 235.72 287.75
Raw Material
60.55 96.21 110.4 167.65 175.78
Increase Decrease in Cost
-1.77 -1.75 -4.71 -18.24 -4.42
Other Manufacturing Expense
13.4 17.78 24.29 31.79 0
Employee Cost
10.88 15.91 22.7 25.89 33.97
Miscellaneous Expenses
8.32 12.99 21.31 28.63 82.42
Operating Profit
24.74 42.7 53.12 59.99 74.61
Other Income
0.5 0.76 0.75 1.36 6.44
Depreciation
6.87 7.25 10.41 9.78 12.51
Interest
2.42 1.9 2.41 2.82 6.99
Profit before tax and exceptio..
15.95 34.3 41.06 48.75 61.54
Exceptional Items
0 0 0 0 -4.57
PBT
15.95 34.3 41.06 48.75 56.97
Provision for Taxation
4.23 9.47 10.34 12.32 14.55
Net Profit
11.72 24.83 30.72 36.44 42.42
NET Profit after MI
11.72 24.83 30.72 36.44 42.42
EPS
12.2 25.82 31.95 37.9 42.02
Operating Profit Margin (%)
21.31 23.23 23.39 20.29 20.59
Net Profit Margin (%)
10.09 13.51 13.53 12.32 11.71

Beta Drugs Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 66.70 66.70 66.70 66.70 66.70
FII 0.90 1.20 1.20 0.90 0.30
MF 0.00 0.00 0.00 0.00 0.00
Others 0.20 0.10 0.10 0.10 0.10
Shareholder Shares Holding %
Download Our App On: